AstraZeneca

Stocking up on biotech stocks is going to mean a big year for deals.  Who can benefit.

Stocking up on biotech stocks is going to mean a big year for deals. Who can benefit.

Nearly two years after biotech stocks began to crash, small- and mid-cap executives in the space finally accept that stock prices aren’t going down anytime soon. As reality sets in, it’s become a buyer’s market for companies looking for acquisitions and partnerships, according to several pharma and medical technology executives gathered this year. JPMorgan Healthcare …

Stocking up on biotech stocks is going to mean a big year for deals. Who can benefit. Read More »

Live Updates: AstraZeneca buys US biotech company CinCor in a $1.8 deal

Live Updates: AstraZeneca buys US biotech company CinCor in a $1.8 deal

Amid the economic gloom and ongoing conflict in Ukraine, there are signs that things are returning to normal. The Golden Globes are back this week at their home in Los Angeles, after interruptions over a lack of diversity led to last year’s cancellation of the event. Looking ahead, world leaders, business leaders and economic thinkers …

Live Updates: AstraZeneca buys US biotech company CinCor in a $1.8 deal Read More »